Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL
Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an...
Gespeichert in:
Veröffentlicht in: | Blood 2021-07, Vol.138 (2), p.122-135 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 135 |
---|---|
container_issue | 2 |
container_start_page | 122 |
container_title | Blood |
container_volume | 138 |
creator | Zheng, Wenting Wei, Jun Zebley, Caitlin C. Jones, Lindsay L. Dhungana, Yogesh Wang, Yong-Dong Mavuluri, Jayadev Long, Lingyun Fan, Yiping Youngblood, Ben Chi, Hongbo Geiger, Terrence L. |
description | Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR–T-cell expansion and memory-like cell formation. This leads to improved CAR-T–mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1–deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR–T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1− CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR–T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR–T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR–T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.
•Regnase-1 deficiency enhances CAR–T-cell persistence and CAR-T–mediated antitumor immunity in murine and human xenograft B-ALL models.•Regnase-1 targets Tcf7 mRNA to inhibit formation of TPEX cells critical for CAR–T-cell recall responses and survival.
[Display omitted] |
doi_str_mv | 10.1182/blood.2020009309 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8288655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497121006352</els_id><sourcerecordid>2500387590</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-ebad37baa7d1434b7721e49b7cc5dff4b1d59463e8f64157d4b52c87b97fe7bf3</originalsourceid><addsrcrecordid>eNp1kcuKFDEUhoMoTju6dyVZClJjkkoqKRdC08yo0CAM7TrkcqonUlUpk6pBd77DvKFPYtpuR124CjnnP9-5_Ag9p-SCUsVe2z5Gf8EII4S0NWkfoBUVTFWkRB6iVYk2FW8lPUNPcv5MCOU1E4_RWV03LVG0WaH-GvajyVBRnJdpSpAzZLzbXFX0FS5ft6QcE4avN2bJM3i8qxz0Pe5iGswc4ojniPswhBlv1tc_vt-d8gU0xfHAMnsTxjzj9Xb7FD3qTJ_h2ek9R5-uLneb99X247sPm_W2cpzLuQJrfC2tMdKXgbmVklHgrZXOCd913FIvWt7UoLqGUyE9t4I5JW0rO5C2q8_R2yN3WuwA3sE4J9PrKYXBpG86mqD_zYzhRu_jrVZMqUaIAnh5AqT4ZYE86yHkw15mhLhkzQQhtZKiJUVKjlKXYs4Juvs2lOiDSfqXSfqPSaXkxd_j3Rf8dqUI3hwFUI50GyDp7AKMDnwojszax_B_-k--ZaRZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2500387590</pqid></control><display><type>article</type><title>Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Zheng, Wenting ; Wei, Jun ; Zebley, Caitlin C. ; Jones, Lindsay L. ; Dhungana, Yogesh ; Wang, Yong-Dong ; Mavuluri, Jayadev ; Long, Lingyun ; Fan, Yiping ; Youngblood, Ben ; Chi, Hongbo ; Geiger, Terrence L.</creator><creatorcontrib>Zheng, Wenting ; Wei, Jun ; Zebley, Caitlin C. ; Jones, Lindsay L. ; Dhungana, Yogesh ; Wang, Yong-Dong ; Mavuluri, Jayadev ; Long, Lingyun ; Fan, Yiping ; Youngblood, Ben ; Chi, Hongbo ; Geiger, Terrence L.</creatorcontrib><description>Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR–T-cell expansion and memory-like cell formation. This leads to improved CAR-T–mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1–deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR–T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1− CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR–T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR–T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR–T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.
•Regnase-1 deficiency enhances CAR–T-cell persistence and CAR-T–mediated antitumor immunity in murine and human xenograft B-ALL models.•Regnase-1 targets Tcf7 mRNA to inhibit formation of TPEX cells critical for CAR–T-cell recall responses and survival.
[Display omitted]</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.2020009309</identifier><identifier>PMID: 33690816</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antigens, CD19 - metabolism ; Cell Line, Tumor ; Cellular Reprogramming ; Disease Models, Animal ; Epigenesis, Genetic ; Humans ; Immunobiology and Immunotherapy ; Immunocompetence - immunology ; Immunologic Memory ; Immunotherapy, Adoptive ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Phenotype ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy ; Ribonucleases - metabolism ; T Cell Transcription Factor 1 - metabolism ; T-Lymphocytes - immunology</subject><ispartof>Blood, 2021-07, Vol.138 (2), p.122-135</ispartof><rights>2021 American Society of Hematology</rights><rights>2021 by The American Society of Hematology.</rights><rights>2021 by The American Society of Hematology 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-ebad37baa7d1434b7721e49b7cc5dff4b1d59463e8f64157d4b52c87b97fe7bf3</citedby><cites>FETCH-LOGICAL-c447t-ebad37baa7d1434b7721e49b7cc5dff4b1d59463e8f64157d4b52c87b97fe7bf3</cites><orcidid>0000-0003-4360-6451 ; 0000-0001-8751-9216 ; 0000-0002-8430-4620 ; 0000-0001-8290-5732</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33690816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Wenting</creatorcontrib><creatorcontrib>Wei, Jun</creatorcontrib><creatorcontrib>Zebley, Caitlin C.</creatorcontrib><creatorcontrib>Jones, Lindsay L.</creatorcontrib><creatorcontrib>Dhungana, Yogesh</creatorcontrib><creatorcontrib>Wang, Yong-Dong</creatorcontrib><creatorcontrib>Mavuluri, Jayadev</creatorcontrib><creatorcontrib>Long, Lingyun</creatorcontrib><creatorcontrib>Fan, Yiping</creatorcontrib><creatorcontrib>Youngblood, Ben</creatorcontrib><creatorcontrib>Chi, Hongbo</creatorcontrib><creatorcontrib>Geiger, Terrence L.</creatorcontrib><title>Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL</title><title>Blood</title><addtitle>Blood</addtitle><description>Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR–T-cell expansion and memory-like cell formation. This leads to improved CAR-T–mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1–deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR–T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1− CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR–T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR–T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR–T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.
•Regnase-1 deficiency enhances CAR–T-cell persistence and CAR-T–mediated antitumor immunity in murine and human xenograft B-ALL models.•Regnase-1 targets Tcf7 mRNA to inhibit formation of TPEX cells critical for CAR–T-cell recall responses and survival.
[Display omitted]</description><subject>Animals</subject><subject>Antigens, CD19 - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cellular Reprogramming</subject><subject>Disease Models, Animal</subject><subject>Epigenesis, Genetic</subject><subject>Humans</subject><subject>Immunobiology and Immunotherapy</subject><subject>Immunocompetence - immunology</subject><subject>Immunologic Memory</subject><subject>Immunotherapy, Adoptive</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Phenotype</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy</subject><subject>Ribonucleases - metabolism</subject><subject>T Cell Transcription Factor 1 - metabolism</subject><subject>T-Lymphocytes - immunology</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcuKFDEUhoMoTju6dyVZClJjkkoqKRdC08yo0CAM7TrkcqonUlUpk6pBd77DvKFPYtpuR124CjnnP9-5_Ag9p-SCUsVe2z5Gf8EII4S0NWkfoBUVTFWkRB6iVYk2FW8lPUNPcv5MCOU1E4_RWV03LVG0WaH-GvajyVBRnJdpSpAzZLzbXFX0FS5ft6QcE4avN2bJM3i8qxz0Pe5iGswc4ojniPswhBlv1tc_vt-d8gU0xfHAMnsTxjzj9Xb7FD3qTJ_h2ek9R5-uLneb99X247sPm_W2cpzLuQJrfC2tMdKXgbmVklHgrZXOCd913FIvWt7UoLqGUyE9t4I5JW0rO5C2q8_R2yN3WuwA3sE4J9PrKYXBpG86mqD_zYzhRu_jrVZMqUaIAnh5AqT4ZYE86yHkw15mhLhkzQQhtZKiJUVKjlKXYs4Juvs2lOiDSfqXSfqPSaXkxd_j3Rf8dqUI3hwFUI50GyDp7AKMDnwojszax_B_-k--ZaRZ</recordid><startdate>20210715</startdate><enddate>20210715</enddate><creator>Zheng, Wenting</creator><creator>Wei, Jun</creator><creator>Zebley, Caitlin C.</creator><creator>Jones, Lindsay L.</creator><creator>Dhungana, Yogesh</creator><creator>Wang, Yong-Dong</creator><creator>Mavuluri, Jayadev</creator><creator>Long, Lingyun</creator><creator>Fan, Yiping</creator><creator>Youngblood, Ben</creator><creator>Chi, Hongbo</creator><creator>Geiger, Terrence L.</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4360-6451</orcidid><orcidid>https://orcid.org/0000-0001-8751-9216</orcidid><orcidid>https://orcid.org/0000-0002-8430-4620</orcidid><orcidid>https://orcid.org/0000-0001-8290-5732</orcidid></search><sort><creationdate>20210715</creationdate><title>Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL</title><author>Zheng, Wenting ; Wei, Jun ; Zebley, Caitlin C. ; Jones, Lindsay L. ; Dhungana, Yogesh ; Wang, Yong-Dong ; Mavuluri, Jayadev ; Long, Lingyun ; Fan, Yiping ; Youngblood, Ben ; Chi, Hongbo ; Geiger, Terrence L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-ebad37baa7d1434b7721e49b7cc5dff4b1d59463e8f64157d4b52c87b97fe7bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antigens, CD19 - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cellular Reprogramming</topic><topic>Disease Models, Animal</topic><topic>Epigenesis, Genetic</topic><topic>Humans</topic><topic>Immunobiology and Immunotherapy</topic><topic>Immunocompetence - immunology</topic><topic>Immunologic Memory</topic><topic>Immunotherapy, Adoptive</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Phenotype</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy</topic><topic>Ribonucleases - metabolism</topic><topic>T Cell Transcription Factor 1 - metabolism</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Wenting</creatorcontrib><creatorcontrib>Wei, Jun</creatorcontrib><creatorcontrib>Zebley, Caitlin C.</creatorcontrib><creatorcontrib>Jones, Lindsay L.</creatorcontrib><creatorcontrib>Dhungana, Yogesh</creatorcontrib><creatorcontrib>Wang, Yong-Dong</creatorcontrib><creatorcontrib>Mavuluri, Jayadev</creatorcontrib><creatorcontrib>Long, Lingyun</creatorcontrib><creatorcontrib>Fan, Yiping</creatorcontrib><creatorcontrib>Youngblood, Ben</creatorcontrib><creatorcontrib>Chi, Hongbo</creatorcontrib><creatorcontrib>Geiger, Terrence L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Wenting</au><au>Wei, Jun</au><au>Zebley, Caitlin C.</au><au>Jones, Lindsay L.</au><au>Dhungana, Yogesh</au><au>Wang, Yong-Dong</au><au>Mavuluri, Jayadev</au><au>Long, Lingyun</au><au>Fan, Yiping</au><au>Youngblood, Ben</au><au>Chi, Hongbo</au><au>Geiger, Terrence L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2021-07-15</date><risdate>2021</risdate><volume>138</volume><issue>2</issue><spage>122</spage><epage>135</epage><pages>122-135</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR–T-cell expansion and memory-like cell formation. This leads to improved CAR-T–mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1–deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR–T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1− CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR–T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR–T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR–T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.
•Regnase-1 deficiency enhances CAR–T-cell persistence and CAR-T–mediated antitumor immunity in murine and human xenograft B-ALL models.•Regnase-1 targets Tcf7 mRNA to inhibit formation of TPEX cells critical for CAR–T-cell recall responses and survival.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33690816</pmid><doi>10.1182/blood.2020009309</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-4360-6451</orcidid><orcidid>https://orcid.org/0000-0001-8751-9216</orcidid><orcidid>https://orcid.org/0000-0002-8430-4620</orcidid><orcidid>https://orcid.org/0000-0001-8290-5732</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2021-07, Vol.138 (2), p.122-135 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8288655 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Antigens, CD19 - metabolism Cell Line, Tumor Cellular Reprogramming Disease Models, Animal Epigenesis, Genetic Humans Immunobiology and Immunotherapy Immunocompetence - immunology Immunologic Memory Immunotherapy, Adoptive Mice Mice, Inbred C57BL Mice, Transgenic Phenotype Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Ribonucleases - metabolism T Cell Transcription Factor 1 - metabolism T-Lymphocytes - immunology |
title | Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T07%3A01%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regnase-1%20suppresses%20TCF-1+%20precursor%20exhausted%20T-cell%20formation%20to%20limit%20CAR%E2%80%93T-cell%20responses%20against%20ALL&rft.jtitle=Blood&rft.au=Zheng,%20Wenting&rft.date=2021-07-15&rft.volume=138&rft.issue=2&rft.spage=122&rft.epage=135&rft.pages=122-135&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.2020009309&rft_dat=%3Cproquest_pubme%3E2500387590%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2500387590&rft_id=info:pmid/33690816&rft_els_id=S0006497121006352&rfr_iscdi=true |